ST. LOUIS – Irritable Bowel Syndrome (IBS) affects millions of Americans, but many people may not even know they have it.

Researchers examined the relationship between a diet that provokes inflammation and the risk for irritable bowel syndrome.

Researchers at the University of Vienna have developed gut-stable oxytocin analogues designed for targeted treatment of ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

Risk factors for IBS may include HIV infection; however, additional large-scale studies are necessary to draw sound conclusions.

A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...